SCHEMBL19903692

SCHEMBL19903692

N#Cc1c(-n2c3cc(-c4ccccc4)ccc3c3ccc(-c4ccccc4)cc32)cc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1-n1c2cc(-c3ccccc3)ccc2c2ccc(-c3ccccc3)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 4/20 0.39
RXRG P48443 3/20 0.39
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KIF11 P52732 2/20 0.37
RXRB P28702 3/20 0.37
NAAA Q02083 2/20 0.35
ICMT O60725 1/20 0.35
GLO1 Q04760 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
TACR1 P25103 2/20 0.33
PTPN5 P54829 1/20 0.33
KDM4A O75164 1/20 0.33
KDM5B Q9UGL1 1/20 0.33
LDHA P00338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19917999 0.96 RXRA (0.37) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL20617071 0.94 RXRA (0.47) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL19918047 0.94 RXRA (0.38) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL19918048 0.93 KIF11 (0.38) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL19912527 0.92 AR (0.37) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL22822504 0.91 RXRA (0.45) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL19903457 0.90 KIF11 (0.47) RXRARXRGSMN1; SMN2KIF11RXRB
SCHEMBL19903526 0.90 RXRA (0.39) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL19917980 0.90 CTSS (0.38) RXRARXRGALDH1A1SMN1; SMN2MAPT
SCHEMBL19903461 0.90 KIF11 (0.42) RXRARXRGKIF11NAAATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 RXRA 3779/4885RXRG 3669/4885ALDH1A1 901/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 RXRA 3635/4885RXRG 3474/4885ALDH1A1 817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.